There is no good argument to legalize marijuana and no arugument valid to support retail sales. But let’s not let science get in the way of politics and government revenue sources.
Concerns About Cannabis Delegates also debated a report from the AMA Council on Science and Public Health regarding the public health impacts of cannabis legislation. The report noted that current AMA policy “categorizes cannabis as a dangerous drug and public health concern” and believes that its sale to adults “should not be legalized,” and that “With respect to criminal penalties, our AMA believes that public health-based strategies, rather than incarceration, should be utilized in the handling of individuals possessing cannabis for personal use. A plea of cannabis intoxication should not be a defense in any criminal proceedings.”
The report recommended adding to AMA policy a suggestion for states that have already legalized cannabis to “regulate retail sales, marketing, and promotion intended to encourage use; limit the potency of cannabis extracts and concentrates; require packaging to convey meaningful and easily understood units of consumption, and require that for commercially available edibles, packaging must be child-resistant and come with messaging about the hazards about unintentional ingestion in children and youth.”
The report also affirmed that the AMA “will advocate for stronger public health messaging on the health effects of cannabis and cannabinoid inhalation and ingestion, with an emphasis on reducing initiation and frequency of cannabis use among adolescents, especially high potency products; use among women who are pregnant or contemplating pregnancy; and avoiding cannabis-impaired driving;” and that the AMA “supports social equity programs to address the impacts of cannabis prohibition and enforcement policies that have disproportionately impacted marginalized and minoritized communities.”